Page
%P
-
Article
Open AccessTargeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma
Adrenocortical carcinoma (ACC) is an aggressive cancer with a 5 year survival rate of 20–30 %. Various factors have been implicated in the pathogenesis of ACC including dysregulation of the G2/M transition and...